Drug Shortage Report for SUPRAX

Last updated on 2018-05-25 History
Report ID 45974
Drug Identification Number 00868965
Brand name SUPRAX
Common or Proper name Cefixime for oral suspension
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) CEFIXIME
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 50 mL
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-04-16
Estimated end date 2018-05-25
Actual end date 2018-05-24
Shortage status Resolved
Updated date 2018-05-25
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-04-16 English Compare
v2 2018-04-16 French Compare
v3 2018-04-17 English Compare
v4 2018-05-04 English Compare
v5 2018-05-04 French Compare
v6 2018-05-15 English Compare
v7 2018-05-15 French Compare
v8 2018-05-22 English Compare
v9 2018-05-22 French Compare
v10 2018-05-24 English Compare
v11 2018-05-24 French Compare
v12 2018-05-25 English Compare

Showing 1 to 12 of 12